logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Neuroendocrine Tumors

    FiltersReset Filters
    6 results

    • detectnet

      (copper Cu 64 Dotatate)
      CURIUM US LLC
      Usage: Detectnet is indicated for use with positron emission tomography (PET) to localize somatostatin receptor positive neuroendocrine tumors (NETs) in adult patients.

    • ga-68-dotatoc

      (EDOTREOTIDE GALLIUM GA-68)
      UIHC – P E T Imaging Center
      Usage: Ga 68 DOTATOC Injection is indicated for use with PET to localize somatostatin receptor positive neuroendocrine tumors (NETs) in both adult and pediatric patients.

    • kit for the preparation of indium in 111 pentetreotide

      (Indium In-111 Pentetreotide)
      Sun Pharmaceutical Industries, Inc.
      Usage: Indium In-111 pentetreotide injection is used for scintigraphic localization of primary and metastatic neuroendocrine tumors that express somatostatin receptors.

    • netspot

      (68Ga-DOTATATE)
      Advanced Accelerator Applications USA, Inc
      Usage: NETSPOT, after gallium-68 radiolabeling, is indicated for use with positron emission tomography (PET) to localize somatostatin receptor-positive neuroendocrine tumors (NETs) in both adult and pediatric patients.

    • octreoscan

      (Indium In -111 Pentetreotide)
      Curium US LLC
      Usage: Octreoscan is used for scintigraphic localization of primary and metastatic neuroendocrine tumors that express somatostatin receptors, following radiolabeling.

    • somatuline depot

      (lanreotide acetate)
      Ipsen Biopharmaceuticals, Inc.
      Usage: SOMATULINE DEPOT is indicated for long-term treatment of acromegaly, unresectable gastroenteropancreatic neuroendocrine tumors (GEP-NETs), and carcinoid syndrome in adults. It aims to normalize growth hormone levels, improve progression-free survival in GEP-NETs, and reduce the need for short-acting somatostatin analog rescue therapy in carcinoid syndrome.